A novel series of melatonin receptor ligands was discovered by opening the cyclic scaffolds of knownclasses of high affinity melatonin receptor antagonists, while retaining the pharmacophore elements postulatedby previously described 3D-QSAR and receptor models. Compounds belonging to the classes of 2,3- and[3,3-diphenylprop(en)yl]alkanamides and of
o- or [(
m-benzyl)phenyl]ethyl-alkanamides were synthesizedand tested on MT
1 and MT
2 receptors. The class of 3,3-diphenyl-propenyl-alkanamides was the mostinteresting one, with compounds having MT
2 receptor affinity similar to that of MLT, remarkable MT
2selectivity, and partial agonist or antagonist behavior. In particular, the (
E)-
m-methoxy cyclobutanecarboxamido derivative
18f and the di-(
m-methoxy) acetamido one,
18g, have sub-nM affinity for the MT
2subtype, with more than 100-fold selectivity over MT
1,
18f being an antagonist and
18g a partial agonist onGTP
![](/images/gifchars/gamma.gif)
S test. Docking of
18g into a previously developed MT
2 receptor model showed a binding schemeconsistent with that of other antagonists. The MT
2 expected binding affinities of the new compounds werecalculated by a previously developed 3D-QSAR CoMFA model, giving satisfactory predictions.